Ticker Details
Adaptive Biotechnologies Corporation
IPO Date:	June 24, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.06B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.60 | 3.25%
Avg Daily Range (30 D):	$0.43 | 3.01%
Avg Daily Range (90 D):	$0.42 | 2.64%

Institutional Daily Volume
Avg Daily Volume:	1.12M
Avg Daily Volume (30 D):	1.9M
Avg Daily Volume (90 D):	1.87M

Trade Size
Avg Trade Size (Sh.):	90
Avg Trade Size (Sh.) (30 D):	68
Avg Trade Size (Sh.) (90 D):	71

Institutional Trades
Total Institutional Trades:	2,952
Avg Institutional Trade:	$1.98M
Avg Institutional Trade (30 D):	$2.84M
Avg Institutional Trade (90 D):	$2.79M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.49M
Avg Closing Trade (30 D):	$3.74M
Avg Closing Trade (90 D):	$4.23M
Avg Closing Volume:	152.62K

News

Apr 8, 2026 @ 1:13 PM Adaptive Biotech Insider Sells $554K as Revenue Ju... Source: Jonathan Ponciano

Mar 31, 2026 @ 12:08 AM Adaptive Biotech's President Trimmed Her Position.... Source: Seena Hassouna

Mar 26, 2026 @ 4:13 PM Adaptive Biotech Insider Sale of 180,000 Shares Ti... Source: Jonathan Ponciano

Dec 15, 2025 @ 5:31 PM Pfizer Faces Another Quiet Year As Patent Losses C... Source: Vandana Singh

Dec 6, 2025 @ 1:30 PM Adaptive Biotechnologies Showcases Leadership in H... Source: Adaptive Biotechnologies Corporation

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.39	$-.09	$-.39
Diluted EPS	$-.39	$-.09	$-.39
Revenue	$276.98M	$71.68M	$276.98M
Gross Profit	$205.62M	$53.46M	$205.62M
Net Income / Loss	$-59.46M	$-13.58M	$-59.46M
Operating Income / Loss	$-57.12M	$-12.77M	$-57.12M
Cost of Revenue	$71.36M	$18.22M	$71.36M
Net Cash Flow	$22.37M	$15.46M	$22.37M
PE Ratio